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Abstract
Background The diagnosis of myocarditis continues to be
a challenging task in clinical practice. The purpose of our
study was to investigate cardiovascular magnetic resonance
imaging in the diagnostic workup of ambulatory patients
with the suspicion of early myocarditis after respiratory or
gastrointestinal tract viral infection. The need for accurate
diagnosis of early myocarditis arises from the low diag-
nostic accuracy of routine clinical tests.
Methods We examined 67 consecutive patients with
symptoms of weakness, palpitations, and fatigue after
respiratory or gastrointestinal tract infection. We compared
these patients to 31 controls. ECG-triggered, T2-weighted,
fast-spin-echo triple inversion recovery sequences and
delayed enhancement imaging were obtained in all
patients, as well as functional parameters of left ventricular
function and dimensions. In addition, in 25 patients and 10
controls, ECG-triggered, T1-weighted, multi-slice spin-
echo images were obtained in axial orientation.
Results We found a signiﬁcant difference between
patients with suspected myocarditis and controls in
T2-global myocardial signal intensity. In addition, the ratio
of global myocardial signal intensity/muscle signal inten-
sity was 2.3 ± 0.4 in patients and 1.8 ± 0.3 in controls,
which was highly signiﬁcant (p\0.001). In 23 patients, a
pathological late enhancement pattern was seen, but only in
one of the controls. There was no signiﬁcant difference in
T1-signal parameters.
Conclusion Cardiovascular magnetic resonance tech-
nique is able to detect early myocardial involvement after
respiratory or gastrointestinal tract infection.
Keywords Cardiovascular magnetic resonance imaging 
Myocarditis  Triple inversion recovery sequence 
Respiratory and gastrointestinal tract viral infection 
T2-imaging  STIR
Abbreviations
CMR Cardiovascular magnetic resonance
ECG Electrocardiogram
STIR Spin-echo triple inversion recovery sequences
GD-DTPA Gadolinium-diethylenetriaminepentaacetate
LGE Late gadolinium enhancement
Introduction
Clinical presentations of myocarditis range from non-
speciﬁc systemic symptoms (fever, myalgias, palpitations,
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DOI 10.1007/s00392-010-0173-3or exertional dyspnea) to fulminant hemodynamic collapse
and sudden death. The extreme diversity of clinical mani-
festations has made the true incidence of myocarditis dif-
ﬁcult to determine. Recent prospective postmortem data
have implicated myocarditis in sudden cardiac death of
young adults at rates of 8.6–12% [1, 2]. Furthermore, it has
been identiﬁed as a cause of dilated cardiomyopathy in 9%
of cases in a large prospective series [3]. Myocarditis is
pathologically deﬁned as ‘‘inﬂammation of the myocar-
dium’’. However, despite this seemingly rather clear-cut
deﬁnition, the diagnosis of myocarditis continues to be a
challenging task in clinical practice.
During the past two decades, cardiovascular magnetic
resonance (CMR) has evolved from a research tool to a
clinically validated, safe and comprehensive imaging
modality. It provides anatomic and functional information
in acquired and congenital heart disease and is the most
precise technique for quantiﬁcation of ventricular volumes,
function and mass. Delayed contrast enhancement is an
accurate and robust method used in the diagnosis of
ischemic, non-ischemic cardiomyopathies and myocarditis
[4–8].
The diagnosis of myocardial involvement after viral
infections is generally supported by the ECG (ST segment
changes, arrhythmia, AV block), laboratory tests (troponin
T or I, myoglobin, creatine kinase) and echocardiography
(impairment of systolic or diastolic left ventricular function
or increased wall thickness) [8, 9]. ECG abnormalities are
usually transient and non-speciﬁc, whereas several patients
have no electrocardiographic abnormalities [10–12]. In
fact, some patients with a normal ECG and negative tro-
ponin or creatine kinase test may still have (suspected)
myocarditis after or during a viral infection of the respi-
ratory or gastrointestinal tract [13, 14].
On these grounds, the aims of the present study were (1)
to examine ambulatory patients with suspicion of myo-
cardial involvement after respiratory tract or gastrointesti-
nal infection using CMR; (2) to assess different new CMR
modalities in their practicability in decision-making. When
compared with our pilot study [13], we examined a larger
cohort and tested different modalities including T1 mea-
surements and the late enhancement technique.
Methods
Patients
We prospectively examined 71 consecutive patients who
were referred by general practitioners to an ambulatory
cardiologic examination with suspicion of myocardial
involvement after a viral infection. The patients showed
symptoms of fatigue, weakness and/or palpitations or
precordial discomfort after respiratory or gastrointestinal
tract infections. Inclusion criteria were an infection during
the last 12 weeks and ongoing symptoms. A CMR exam-
ination was performed. The results of these patients were
compared with sex- and age-matched 31 healthy controls.
All patients were carefully interviewed and examined by
experienced cardiologists. Physical examination, ECG,
blood pressure, laboratory testing, and echocardiographic
evaluation were performed and a written informed consent
was obtained from each subject.
One patient experienced claustrophobia during the CMR
examination. In one patient, the image quality of the late
enhancement was insufﬁcient. In another, the image quality
of the STIR sequence was not readable. One patient
developed a contrast allergy after application of gadolin-
ium. All these patients were excluded from analysis. Thus,
the ﬁnal cohort comprised 67 patients.
Magnetic resonance imaging
All images were acquired on a 1.5-T magnetic resonance
system (Intera CV 1.5T, Philips, Best, The Netherlands)
and speciﬁcally designed software (Release 11, Philips).
The functional and morphological data were evaluated by
the software view forum 6.5 (Philips). Regions of interest
were drawn manually. Dedicated ﬁve element phase-array
cardiac synergy coil was used for signal detection. We used
constant level appearance techniques. Constant level
appearance is a homogeneity correction applied to com-
pensate for signal inhomogeneity attributable to the surface
coils. It is equivalent to a SENSE acquisition with a
SENSE factor of one to acquire the sensitivity maps for
each synergy coil element (relative to the body coil sen-
sitivity) that can be used to get a perfect uniformity cor-
rection. At the beginning of the pilot study, controls were
scanned with cardiac and body coils. Signal homogeneity,
stability, and robustness were better with the cardiac coil.
To evaluate LV function and dimensions, we took 2, 3 and
4-chamber long-axis views and 3-D short axis volume data
assessed by steady-state free precession imaging (ﬁeld of
view 350 mm, matrix 256 9 256, echo time 1.6 ms, rep-
etition time 4.0 ms, ﬂip angle 60, slice thickness 10 mm,
no gap). In all patients, phase-contrast velocity images in
the aorta ascendens were obtained to calculate stroke vol-
ume and to rule out a signiﬁcant aortic insufﬁciency (ﬁeld
of view 300 mm, matrix 256 9 256, echo time 3.7 ms,
repetitions time 6.1 ms, ﬂip angle 25, slice thickness
8 mm).
Diagnosis of myocardial inﬂammation
ECG-triggered, T2-weighted, fast-spin-echo triple inver-
sion recovery sequences (STIR) were performed in all
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123patients and controls in a short axis view covering the
whole left ventricle as previously described [13]. The rel-
ative myocardial signal intensity was calculated by the
ratio of myocardial signal intensity and muscle signal
intensity [15]. The homogeneity of the signal intensity of
the region of interest has been studied intensively at the
start of the pilot study in volunteers and patients. A very
good robustness of the performed STIR sequence showing
a homogeneous signal at different time points in the same
volunteers was found.
In addition, in 25 patients and 10 controls, ECG-trig-
gered, T1-weighted, multi slice spin-echo images were
obtained in axial orientation (3–4 acquisitions, ﬁeld of view
370 mm, matrix size 256 9 256, slice thickness 10 mm,
no gap, echo time 20 ms, ﬂip angle 90, relaxation time
480–725 ms) with identical parameters before and in 21
patients and 9 controls after intravenous bolus of
0.1 mmol/kg gadolinium-diethylenetriaminepentaacetate
(Gd-DTPA) (Magnevist, Schering AG, Germany) (early
phase, 1–2 min after bolus injection) A saturation slice
across the atria was positioned to reduce signals from slow-
ﬂowing blood into the left ventricle. The signal intensity in
the myocardial wall and in the skeletal muscles was mea-
sured; 5–10 regions of interest were drawn into the septum,
anterior, and lateral wall before and after application of
Gd-DTPA. In addition, 5–10 regions of interests were
drawn into the skeletal muscles (erector spinae muscle or
lattissimus dorsi) with homogenous signal. The relative
myocardial signal intensity was calculated by the following
formula: intensity after Gd-DTPA minus the intensity
before Gd-DTPA divided by the intensity before Gd-DTPA
ratio of myocardial signal intensity and muscle signal
intensity [15].
Delayed enhancement
Delayed enhancement imaging was obtained 10 min after a
second bolus of 0.1 mmol/kg intravenous gadolinium by
hand injection. 3D inversion recovery turbo gradient echo
sequence (2 acquisitions, ﬁeld of view 330 mm, matrix
size 256 9 256, slice thickness 5 mm, no gap, echo time
1,4 ms, TR shortest, ﬂip angle 15, an inversion time 230–
280 ms) was optimized for each measurement for maximal
myocardial signal suppression. 3D volume of the left
ventricle was obtained covering the complete left ventricle
without gap during two breath holds.
Statistical analysis
Data are presented as mean and standard deviation for
quantitative variables and as absolute and relative fre-
quencies for categorical variables. For the evaluation of
diagnostic parameters, such as speciﬁcity, STIR was
dichotomised at its optimal value. Comparisons of vari-
ables between patients and controls were performed by
means of Wilcoxon’s rank tests. All tests were two-sided
and used a signiﬁcance level of 0.05 to indicate statistical
signiﬁcance. A percent segmental agreement between
STIR values and LGE was obtained in the 23 patients who
presented with positive LGE.
Results
Patient characteristics
Patient baseline characteristics are shown in Table 1. Only
four patients had to be admitted to the hospital, one female
patient with a rapidly deteriorating LV function with a
minimal ejection fraction of 20% and one patient with
additional pericardial effusion. Two other patients were
admitted for chest pain to exclude an acute coronary syn-
drome. In two patients, a biopsy was performed and parvo
B 19 virus was detected. All the other patients were
dealt with as outpatients. In several patients documented
ventricular or atrial premature beats remained over
time, whereas the other ones completely recovered. The
patients were followed as outpatients for up to 5 years
(6–60 months, median 32.9 ± 13.4 months). One patient
is developing dilatative cardiomyopathy, left ventricular
function actually is 49%, LVEDD 62 mm, in another
patient function remains 50% with normal diameters. LV
function is normal in the remaining patients ([50%). In the
acute phase, the symptomatic patients with ventricular
premature beats were treated with potassium, magnesium
Table 1 Clinical characteristics of the 67 patients
Variable (%) Patients
Male sex 45 (67)
Weakness 50 (75)
Fatigue 44 (66)
Dyspnea 26 (39)
Palpitations 22 (33)
Chest pain 5 (7)
Ventricular premature beats 13 (19)
Atrial premature beats 6 (9)
New onset atrial ﬁbrillation 4 (6)
Left bundle branch or hemi-block 5 (7)
New ST/T-changes 5 (7)
Small pericardial effusion 8 (12)
One patient had a new sinoatrial exit block, one patient a new right
deviation of the electrical position of the heart. Some patients had
more than one symptom
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123and low-dose beta-blockers on an individual basis. Patients
with severe exertional dyspnea and borderline ejection
fraction were treated in addition with ACE inhibitors. All
patients were advised to avoid any physical activities
during the acute phase.
Functional parameters
The values are listed in Table 2. Left ventricular ejection
fraction was slightly lower in patients versus controls. No
control had a left ventricular function below 55%, whereas
six patients had a function of 55% or less (minimal 52%).
There were no signiﬁcant differences in stroke volume,
cardiac output, left ventricular end-diastolic volume, and
left ventricular end-diastolic diameter between patients and
controls.
Diagnosis of inﬂammation
STIR (T2-weighted imaging)
We found a signiﬁcant difference between patients with
suspected myocarditis and controls in global myocardial
signal intensity, in the signal intensity of the septum,
anterior, lateral, and inferior wall. The ratios of septal,
anterior, lateral, and inferior myocardial signal intensity/
muscle signal intensity were also signiﬁcantly higher in
patients as compared to controls (Table 3). Figures 1 and 2
depict examples of two patients. The signal of the skeletal
muscle was very similar in patients and controls.
Thebestcutoffvaluetodifferentiatepatientsandcontrols
was 2.14 (global myocardial signal intensity/muscle signal
intensity). The sensitivity was 74.5%, the speciﬁcity 93.5%,
the positive-predictive value 96.2%, and the negative-pre-
dictive value 63.0%, and the diagnostic accuracy 80.6%.
We performed a percent segmental agreement and found
a correlation regarding the ratios of septal, anterior, lateral,
and inferior myocardial signal intensity/muscle signal
intensity and a positive late enhancement in the corre-
sponding area in 17 of 23 cases (74%). The myocardial
signal intensity of the septum, anterior, lateral, and inferior
wall corresponded in 13 of 23 cases (57%).
Contrast media-enhanced T1-weighted images
In the ﬁrst 25 patients and ﬁrst 10 controls, the myocardial
signal intensity before contrast application was 603 ± 162
in patients and 639 ± 188 in controls, after contrast
application 913 ± 163 and 965 ± 160, n.s. The ratio of
myocardial and muscle signal intensity was 1.4 ± 0.3 in
patients and 1.8 ± 0.4 in controls, n.s., before, and was
2.1 ± 0.6 versus 1.8 ± 0.4 after gadolinium, n.s. The rel-
ative enhancement had a range from ?43 to -4 in patients
and from ?4t o-107 in controls and was not interpretable.
Therefore, we stopped the T1 approach after the ﬁrst 25
patients and 10 controls.
Delayed gadolinium-enhanced imaging
Contrast enhancement was present in 23 of 67 patients
(34%), p = 0.001 versus controls. Regions of contrast
enhancement were usually seen in a patchy distribution
originating primarily from the epicardial quartile or mid-
myocardial location of the wall with one or several foci
within the myocardium and were most frequently located
in the septum and in the lateral free wall (14 patients)
(Figs. 3, 4). Ten of these patients had a septal and lateral
location. One patient had a location in the inferior wall and
three patients had a diffuse enhanced myocardium. Con-
trast enhancement was never found originating from the
subendocardial portion of the wall, as would be typical for
myocardial infarction. In the control group, only one
patient had a small lateral mid-myocardial enhancement.
Patients with fatigue and weakness after respiratory
infection and no cardiac involvement
Nine of the 67 patients had mild symptoms with fatigue
and weakness after a respiratory infection, but no new
palpitations and no new documented premature beats or
Table 2 Magnetic resonance functional measurements in control subjects and patients
Variable Patients (n = 67) Controls (n = 31) p value
Mean age [years (SD)] 50.1 ± 14.8 53.9 ± 15.7 0.18
Ejection fraction (%) 60.0 ± 5.5 62.8 ± 5.3 0.02
Stroke volume (mL) 91.5 ± 20.6 95.3 ± 21.8 0.67
LV end-diastolic volume (mL) 154.0 ± 33.3 150.0 ± 36.6 0.38
LV end-diastolic diameter (mm) 52.3 ± 4.8 51.9 ± 4.1 0.50
Cardiac output (L/min) 6.2 ± 1.1 6.8 ± 1.7 0.13
Values are expressed as mean ± standard deviation
LV left ventricular
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123other rhythm disturbances. Thus, on a clinical basis, an
overt myocarditis would be less likely. The mean age was
52 years, male sex 7 (78%), global myocardial signal
intensity was 553 ± 139 and the ratio of global myocardial
signal intensity/muscle signal intensity was 2.1 ± 0.3, thus
in the range between patients and controls.
Discussion
We found a high prevalence of myocardial inﬂammation in
patients with symptoms of fatigue, weakness, and/or pal-
pitations after respiratory tract or gastrointestinal infection.
In addition, one-third of patients had a mid-myocardial or
subepicardial late gadolinium enhancement indicating
ﬁbrosis of non-ischemic injury. Thus, CMR is able to make
a positive diagnosis of myocarditis and add substantial
diagnostic information to the standard approach with ECG,
laboratory values and echocardiography.
The need for accurate diagnosis of early myocarditis
arises from the low diagnostic accuracy of routine clinical
tests. Even a negative troponin test and absence of ST
elevation or depression cannot rule out an early form of
myocarditis [8, 14]. In our study, we found that patients
with suspected myocarditis had a highly signiﬁcant ele-
vated signal intensity of the myocardium as compared to
controls. This indicates edematous tissue that may reﬂect
cardiac involvement as the ﬁrst step of myocarditis.
Table 3 Magnetic resonance measurements of inﬂammation in control subjects and patients
Variable Patients (n = 67) Controls (n = 31) p value
STIR of the left ventricular myocardium 668 ± 288 526 ± 91 \0.001
STIR of the skeletal muscle 288 ± 51 294 ± 62 0.55
STIR myocardium/skeletal muscle 2.3 ± 0.4 1.8 ± 0.3 \0.001
STIR of the septum 686 ± 135 546 ± 100 \0.001
STIR septum/skeletal muscle 2.4 ± 0.4 1.9 ± 0.3 \0.001
STIR of the anterior wall 648 ± 157 498 ± 99 \0.001
STIR anterior wall/skeletal muscle 2.3 ± 0.4 1.7 ± 0.3 \0.001
STIR of the lateral wall 679 ± 140 515 ± 97 \0.001
STIR lateral wall/skeletal muscle 2.4 ± 0.4 1.8 ± 0.3 \0.001
Values are expressed as mean ± standard deviation
STIR T2-weighted, fast-spin-echo triple inversion recovery sequences
Fig. 1 An example of T2-weighted (STIR) image of a patient
revealing enhanced signal intensity. This provides evidence of
myocardial edema. LV left ventricle, RV right ventricle. Filled
triangle elevated signal intensity of the myocardium
Fig. 2 Another example of T2-weighted (STIR) image of a patient
showing an enhanced signal intensity of the septal wall (ﬁlled
triangle). LV left ventricle, RV right ventricle, PE pericardial effusion
Clin Res Cardiol (2010) 99:707–714 711
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Cardiovascular magnetic resonance is able to provide
detailed information on myocardial tissue characteristics.
Tissue hyperemia is an integral component of the acute
inﬂammatory reaction in the myocardium and can be
detected by T2-weighted imaging. This sequence has been
clinically used to detect edema in acute infarction, sar-
coidosis, and acute rejection following cardiac transplan-
tation [16–18].
In patients with myocarditis, case reports have reported
the use of conventional T2-weighted spin echos [19–22].
New developments, especially a triple inversion breath
hold sequence with short acquisition time (STIR) have led
to a much better image quality. These sequences had been
tested in previous studies [13, 23–25]. The highly signiﬁ-
cant differences in myocardial enhancement between
patients and controls found by this new T2-modality in our
study conﬁrm that CMR is able to diagnose myocardial
involvement in patients with viral infections.
Sensitivity, speciﬁcity, positive predictive value, nega-
tive predictive value and accuracy of a T2-weighted image
were obtained in four previous studies: a higher sensitivity
as compared to our study was found in the study by Rieker
[26] and Abdel-Aty et al. [23], a higher speciﬁcity in the
study of Laissy et al. [27], the accuracy was comparable to
our ﬁndings in the study of Abdel-Aty et al. [23], positive
predictive value was higher in the study of Laissy et al.
[27], but lower in the others, whereas the negative pre-
dictive value was comparable to the study of Gutberlet
et al. [25], and higher in the other studies.
The group of Friedrich and Schulz-Menger et al. [15,
23] examined T1-weighted images, especially contrast
media-enhanced in comparison to healthy volunteers. They
found an increased absolute and relative enhancement
compared with skeletal muscle. These results were con-
ﬁrmed by another group [25]. Gd-DTPA is an approved
extracellular T1-enhancing contrast agent [28] which
increases membrane permeability or increases capillary
blood ﬂow resulting in an increase in volume of distribu-
tion. In our study, we found no signiﬁcant differences in
the absolute or relative T1-weighted images before or after
contrast application. In addition, we found it difﬁcult to
establish stable conditions after the application of Gd-
DTPA. There is a continuous change in the zero run
through after the application of the contrast media, thus
precluding stable conditions.
A difference between our study and the former results
may be the course and extent of myocarditis. We examined
ambulatory patients with normal or only slightly reduced
left ventricular function. In previous studies, the patients
were more seriously sick and needed hospitalization. Thus,
for the very early course of myocarditis, a contrast-
enhanced T1-approach may not be a useful tool.
Late gadolinium enhancement pattern
Normal myocardium does not enhance because extracel-
lularmagneticresonancecontrastagents,suchasGd-DTPA,
Fig. 3 An example of a late enhancement pattern of a patient
illustrating contrast enhancement of the septum and lateral free wall
(ﬁlled triangle). Of notation is the mid-myocardial location. LV left
ventricle, RV right ventricle
Fig. 4 Another example of a late gadolinium enhancement pattern of
a patient showing contrast enhancement of the septum, mid-myocar-
dial location (ﬁlled triangle). Two chamber view; LV left ventricle,
RV right ventricle
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123are excluded from the myocyte intracellular space by intact
sarcolemmal membranes and also, little interstitial space is
available between densely packed myocytes [7]. This
technique has been shown to be effective in identifying the
presence, location, and extent of acute and chronic myo-
cardial infarction [5–7, 29, 30] and other cardiac diseases
[31–33]. Late gadolinium enhancement has been investi-
gated in controlled studies with patients suspected of
having myocarditis [23–25, 34, 35]. Images acquired late
(10–20 min) after application of paramagnetic contrast
agents provide a sensitive tool for detecting myocardial
ﬁbrosis or necrosis, which is distinguished by bright late-
enhancement regions due to the increased volume of dis-
tribution and delayed washout of the contrast agent from
affected myocardium [36]. The major difference to
infarcted regions is that areas of tissue damage within a
myocardiac focus are usually smaller than are areas of
infarcts and the former are dispersed in a patchy pattern
throughout the focus [36, 37].
In our study, all patients had subepicardial or centro-
myocardial location of contrast enhancement and the pre-
ferred locations were lateral and septal. The regions of
contrast enhancement revealed a patchy pattern typical of
non-ischemic injury. The distribution ranged from one to
several foci, and from almost normal to a diffusely
enhanced myocardium. No patient had a subendocardial
location or a location according to territorial distribution of
epicardial vessels. Thus, this study supports the notion that
detection of a subepicardial or centromyocardial scar is
highly suggestive of myocarditis in suspected patients. In
addition, we found that the majority of patients had late-
enhancement regions in the septal and lateral wall. Other
authors [24, 34, 38] found it predominantly lateral, fol-
lowed by a septal location.
We conclude that a subepicardial or centromyocardial
location of contrast enhancement in the septum or lateral
wall within a clinical context suspicious of myocarditis
provides evidence of myocardial involvement.
Study limitations and clinical implications
A major limitation of our study is that biopsies were per-
formed only in two patients. Thus, we have no independent
proof that our patients did indeed suffer from myocarditis.
Myocarditis can be diagnosed with certainty only by
endomyocardial biopsy, which must be examined by his-
tological, immunohistological and molecular techniques to
obtain maximal sensitivity. However, optimal diagnosis of
a biopsy is subject to the problem of sampling error
resulting in a relatively low sensitivity. Furthermore,
myocardial biopsy is in practice used only rarely, despite a
low complication rate [39]. Thus, the diagnosis of myo-
carditis is often based merely on suspicion. In our study,
there were clinical features, such as new palpitations, new
exertional dyspnoea, fatigue, chest pain, and documented
ventricular or atrial premature beats as well as branch
bundle block and other ECG changes that supported the
clinical suspicion of myocarditis. We used a special mod-
ern CMR sequence of inﬂammation (STIR) which has been
used to detect cardiac inﬂammation in previous studies
[23–25, 40], and is recommended in a recent consensus
paper [41]. Thus, we have strong evidence of myocardial
involvement in our patient sample.
We found that the cutoff value of 2.14 had a relatively
high speciﬁcity (ratio of heart to skeletal muscle) in T2-
weighted-STIR images, but a comparable or even lower
sensitivity as compared to others [24, 26–28] which may be
due to different study population and CMR modalities.
In conclusion, in patients with suspected myocarditis,
CMR tomography is helpful in decision-making. With this
technique, it is possible to analyze inﬂammation, edema
and necrosis in addition to functional parameters, such as
left ventricular function, regional wall motion and dimen-
sions. We were able to identify patients with cardiac
involvement after respiratory or gastrointestinal tract viral
infection. Whereas myocarditis may lead to heart failure
this early detection ability may be a promising tool.
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